ALX Oncology Holdings Inc. Stock Forecast
ALX Oncology Holdings Inc. stock price down 0.88% on Friday
(Updated on Mar 31, 2023)
The ALX Oncology Holdings Inc. stock price fell by -0.88% on the last day (Friday, 31st Mar 2023) from $4.56 to $4.52. During the last trading day the stock fluctuated 4.40% from a day low at $4.49 to a day high of $4.69. The price has fallen in 6 of the last 10 days and is down by -5.24% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -17 thousand shares and in total, 168 thousand shares were bought and sold for approximately $761.16 thousand.
Invest in multi-million dollar paintings from just $10k with Masterworks.
The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $4.26, a level that may pose a second chance to hit a runner. According to fan-theory $5.69 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
ALXO Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ALX Oncology Holdings Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.78 and $6.05. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, January 13, 2023, and so far it has fallen -54.85%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for ALX Oncology Holdings Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.198 between high and low, or 4.40%. For the last week the stock has had daily average volatility of 8.38%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ALXO) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect ALX Oncology Holdings Inc. to open at $4.57, and during the day (based on 14 day Average True Range), to move between $4.08 and $4.96, which gives a possible trading interval of +/-$0.439 (+/-9.72%) up or down from last closing price. If ALX Oncology Holdings Inc. takes out the full calculated possible swing range there will be an estimated 19.43% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $4.81, some $0.290 (6.42%) from the current price of $4.52, our system finds the risk reward not very attractive.
Is ALX Oncology Holdings Inc. stock A Buy?
ALX Oncology Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -5.486 Open Broker Account
Strong Sell Candidate UnchangedPredicted Opening Price for ALX Oncology Holdings Inc. of Monday, April 3, 2023
The predicted opening price is based on yesterday's movements between high, low, and closing price.
| Fair opening price April 3, 2023 | Current price |
|---|---|
| $4.57 | $4.52 (Undervalued) |
Remember To Visit Our YouTube Channel
Trading levels for ALXO
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.77 | 5.42 % | |
| R2 | 4.69 | 3.75 % | ||
| R1 | 4.64 | 2.72 % | ||
| Current price: | 4.52 | |||
| Support | S1 | 4.49 | -0.618 % | |
| S2 | 4.45 | -1.65 % | ||
| S3 | 4.37 | -3.32 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.63 | 24.56 % | |
| R2 | 5.00 | 10.62 % | ||
| R1 | 4.81 | 6.42 % | ||
| Current price | 4.52 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy ALX Oncology Holdings Inc. Stock.
About ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
